Clinical Trial

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Name: 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors — clinical trial record (NCT07557225)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.

Protocol Amendment History 2 changes

critical Recruitment opened 2026-05-15

critical Primary endpoint(s) modified 2026-05-05

Trial Details

NCT Number	NCT07557225
Lead Sponsor	Peking University First Hospital
Conditions	Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer, Ovarian Cancer, Head and Neck Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma +6 more
Enrollment	200 participants
Start Date	2026-04-27
Primary Completion	2028-09 (estimated)
Study Completion	2029-03 (estimated)
Updated on ClinicalTrials.gov	2026-05-14